Vancomycin Hydrochloride for Injection recalled over temperature-control failures
- Recall date
- October 6, 2014
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Hospira Inc. recalls Vancomycin Hydrochloride for Injection, USP, 1 g Sterile Powder per Fliptop Vial, packaged in 10 Units per carton, Rx o…
- Recall number
- D-0390-2015
- FDA classification
- Class II
- Brand / firm
- Hospira Inc.
- Sold / distributed
- Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorolac tromethamine 60 mg/2 mL (30 mg/mL), and Propofol 1% 200 mg/20 mL (10 mg/mL), these lots remained within the control of the distributor and were not further distributed. Distribut…
Why it was recalled
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Vancomycin Hydrochloride for Injection, USP, 1 g Sterile Powder per Fliptop Vial, packaged in 10 Units per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-6533-01.
Get recall alerts
Free email alert whenever Hospira Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hospira Inc.